Neoadjuvant chemotherapy is a course of chemotherapy that’s given before your primary treatment, which is often surgery. Neoadjuvant chemotherapy specifically refers to chemotherapy administered ...

For patients with breast cancer, the brain functional network shows a shift toward a more randomized pattern after ...

During a live event, Matthew Galsky, MD discussed neoadjuvant and adjuvant options for a patient case including nivolumab or ...

"The findings suggest that chemotherapy can quickly disrupt brain function in breast cancer patients, potentially ...

27 The AEGEAN trial, KEYNOTE-671, and NADIM II similarly show improvements in EFS and OS using neoadjuvant or perioperative chemoimmunotherapy compared with chemotherapy alone. For a patient with ...

Results from a meta-analysis suggest patients with resectable dMMR/MSI-H gastric cancer can forgo perioperative chemotherapy.

Clinical guidelines should establish clear timelines, and health care systems should prioritize timely treatment initiation and completion,” researchers concluded.

EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer ...

Neal Shore, MD, FACS, discussed findings from the SunRISe-4 trial of TAR-200 and cetrelimab in muscle-invasive bladder cancer ...

Imfinzi in combination with chemotherapy has been approved in the European Union, EU, for the treatment of adults with ...

Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone ...